Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -13.527% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) COc1ccc(OCC(=O)NCCCN2CCOCC2)cc1
b) COc1ncccc1-c1nnn(-c2ccccc2)n1
c) CCC(c1nnnn1C(C)(C)CC)N(CCCN1CCOCC1)Cc1cc2cccc(C)c2[nH]c1=O
Answer: c. CCC(c1nnnn1C(C)(C)CC)N(CCCN1CCOCC1)Cc1cc2cccc(C)c2[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(c1nnnn1C(C)(C)CC)N(CCCN1CCOCC1)Cc1cc2cccc(C)c2[nH]c1=O
CCC(c1nnnn1C(C)(C)CC)N(CCCN1CCOCC1)Cc1cc2cccc(C)c2[nH]c1=O
8-methyl-3-[[1-[1-(2-methylbutan-2-yl)tetrazol-5-yl]propyl-(3-morpholin-4-ylpropyl)amino]methyl]-1H-quinolin-2-one